Page last updated: 2024-08-17

levodopa and Lung Diseases

levodopa has been researched along with Lung Diseases in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (28.57)	18.7374
1990's	2 (28.57)	18.2507
2000's	1 (14.29)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freed, MI; Hampson, NB; Kieburtz, KD; Leinonen, M; LeWitt, PA	1
Melo, A; Monteiro, L; Souza-Machado, A; Valderramas, S	1
Pal, PK; Sathyaprabha, TN; Thennarasu, K; Tuhina, P	1
Bøttcher, J; Grøn, U	1
Eberli, F; Greminger, P; Schmid, PA; Speich, R; Suter, T	1
Kulkantrakorn, K; Petruska, PJ; Selhorst, JB	1
Martin, S	1

Reviews

1 review(s) available for levodopa and Lung Diseases

Article	Year
The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis. Clinical therapeutics, 2012, Volume: 34, Issue:5 Topics: Antiparkinson Agents; Forced Expiratory Volume; Humans; Levodopa; Lung Diseases; Models, Statistical; Parkinson Disease; Peak Expiratory Flow Rate; Vital Capacity	2012

Trials

1 trial(s) available for levodopa and Lung Diseases

Article	Year
Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations. The International journal of neuroscience, 2017, Volume: 127, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Motor Activity; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Spirometry; Treatment Outcome	2017

Article

Year

Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations.

The International journal of neuroscience, 2017, Volume: 127, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Motor Activity; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Spirometry; Treatment Outcome

2017

Other Studies

5 other study(ies) available for levodopa and Lung Diseases

Article	Year
Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa. Movement disorders : official journal of the Movement Disorder Society, 2007, Feb-15, Volume: 22, Issue:3 Topics: Adult; Antiparkinson Agents; Female; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Respiratory Function Tests; Severity of Illness Index	2007
[Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism]. Ugeskrift for laeger, 1981, Oct-05, Volume: 143, Issue:41 Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases	1981
[Bromocriptine-induced pleuropneumopathy]. Deutsche medizinische Wochenschrift (1946), 1994, Nov-11, Volume: 119, Issue:45 Topics: Benserazide; Biperiden; Bromocriptine; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis; Radiography; Selegiline; Time Factors	1994
Cytosine arabinoside and amphotericin B-induced parkinsonism. Annals of neurology, 1996, Volume: 39, Issue:3 Topics: Amphotericin B; Carbidopa; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Levodopa; Lung Diseases; Middle Aged; Parkinson Disease, Secondary	1996
Pharmaceutical review: salbutamol - madopar - isocal. The Lamp, 1978, Volume: 35, Issue:3 Topics: Albuterol; Australia; Benserazide; Humans; Hydrazines; Levodopa; Lung Diseases; Parenteral Nutrition; Parkinson Disease	1978